Stop drug secrecy, says government watchdogBMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6958.831 (Published 01 October 1994) Cite this as: BMJ 1994;309:831
- A Tonks
The British government must take the lead in ending the secrecy surrounding the manufacture, licensing, and marketing of new drugs in Europe, says the National Consumer Council in a report published last week. According to the council, patients are denied access to detailed information on safety, quality, and efficacy of new drugs to protect drug companies from revealing trade secrets to their rivals.
Under a new European drugs regulating system, to be launched next year, drugs approved by the licensing agency in one country will be fast …
Log in using your username and password
Log in through your institution
Sign up for a free trial